The results of the validation of the GEO dataset showed that compared with normal samples, the mRNA expression level of CCL20 and RPL17 in COPD samples were significantly increased (p < 0.05), as shown in Figure 4B. This evidence concerns the gene RPL17 and chronic obstructive pulmonary disease.